LOGIN
ISAKOS2017: GH plus subacromial space CS injection versus GH CS injection alone for frozen shoulder
July 2017
ISAKOS2017: GH plus subacromial space CS injection versus GH CS injection alone for frozen shoulder
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Short term outcome of double side injections of betamethasone for the treatment of early stage idiopathic frozen shoulder.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
126 patients with frozen shoulder were randomized to dual glenohumeral and subacromial injection of betamethasone once per week for 5 weeks, to glenohumeral injection alone once per week for 5 weeks, or to oral non-steroidal anti-inflammatory drugs (NSAIDs) for 5 weeks. Patients were assessed for pain, function, and range of motion over the first 6 months post-treatment. Results demonstrated signi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.